Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)
CNY 10.8
(-0.55%)
CNY 10.8
(-0.55%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.33 Billion CNY | -20.19% |
| 2022 | 1.66 Billion CNY | -8.63% |
| 2021 | 1.82 Billion CNY | -1.57% |
| 2020 | 1.85 Billion CNY | -0.33% |
| 2019 | 1.86 Billion CNY | -32.82% |
| 2018 | 2.77 Billion CNY | 5.46% |
| 2017 | 2.62 Billion CNY | 11.82% |
| 2016 | 2.35 Billion CNY | 13.51% |
| 2015 | 2.07 Billion CNY | 14.29% |
| 2014 | 1.81 Billion CNY | 15.45% |
| 2013 | 1.56 Billion CNY | 9.53% |
| 2012 | 1.43 Billion CNY | 24.67% |
| 2011 | 1.14 Billion CNY | 333.93% |
| 2010 | 264.88 Million CNY | 78.07% |
| 2009 | 148.75 Million CNY | 61.57% |
| 2008 | 92.06 Million CNY | 11.98% |
| 2007 | 82.21 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.28 Billion CNY | -1.32% |
| 2024 Q2 | 1.3 Billion CNY | -0.81% |
| 2024 Q1 | 1.31 Billion CNY | -1.52% |
| 2023 Q3 | 1.48 Billion CNY | -2.59% |
| 2023 FY | 1.33 Billion CNY | -20.19% |
| 2023 Q4 | 1.33 Billion CNY | -10.43% |
| 2023 Q2 | 1.52 Billion CNY | -0.89% |
| 2023 Q1 | 1.54 Billion CNY | -7.71% |
| 2022 Q3 | 1.64 Billion CNY | -1.09% |
| 2022 Q1 | 1.73 Billion CNY | -4.91% |
| 2022 Q2 | 1.66 Billion CNY | -4.33% |
| 2022 FY | 1.66 Billion CNY | -8.63% |
| 2022 Q4 | 1.66 Billion CNY | 1.54% |
| 2021 Q2 | 1.71 Billion CNY | -4.54% |
| 2021 Q4 | 1.82 Billion CNY | 9.1% |
| 2021 FY | 1.82 Billion CNY | -1.57% |
| 2021 Q3 | 1.67 Billion CNY | -2.44% |
| 2021 Q1 | 1.79 Billion CNY | -3.13% |
| 2020 FY | 1.85 Billion CNY | -0.33% |
| 2020 Q1 | 1.79 Billion CNY | -3.64% |
| 2020 Q2 | 1.83 Billion CNY | 2.51% |
| 2020 Q3 | 1.81 Billion CNY | -1.26% |
| 2020 Q4 | 1.85 Billion CNY | 2.19% |
| 2019 FY | 1.86 Billion CNY | -32.82% |
| 2019 Q4 | 1.86 Billion CNY | 0.69% |
| 2019 Q3 | 1.84 Billion CNY | -0.81% |
| 2019 Q1 | 2.75 Billion CNY | -0.47% |
| 2019 Q2 | 1.86 Billion CNY | -32.41% |
| 2018 Q2 | 2.74 Billion CNY | 5.63% |
| 2018 Q1 | 2.6 Billion CNY | -0.99% |
| 2018 Q4 | 2.77 Billion CNY | 0.03% |
| 2018 Q3 | 2.77 Billion CNY | 0.81% |
| 2018 FY | 2.77 Billion CNY | 5.46% |
| 2017 Q3 | 2.47 Billion CNY | 2.55% |
| 2017 Q2 | 2.41 Billion CNY | -0.79% |
| 2017 Q1 | 2.43 Billion CNY | 3.55% |
| 2017 FY | 2.62 Billion CNY | 11.82% |
| 2017 Q4 | 2.62 Billion CNY | 6.14% |
| 2016 Q1 | 2.13 Billion CNY | 2.92% |
| 2016 Q3 | 2.23 Billion CNY | 6.39% |
| 2016 Q2 | 2.1 Billion CNY | -1.27% |
| 2016 FY | 2.35 Billion CNY | 13.51% |
| 2016 Q4 | 2.35 Billion CNY | 4.99% |
| 2015 Q3 | 1.94 Billion CNY | 6.61% |
| 2015 FY | 2.07 Billion CNY | 14.29% |
| 2015 Q1 | 1.82 Billion CNY | 0.82% |
| 2015 Q2 | 1.81 Billion CNY | -0.38% |
| 2015 Q4 | 2.07 Billion CNY | 6.74% |
| 2014 Q4 | 1.81 Billion CNY | 4.92% |
| 2014 Q3 | 1.72 Billion CNY | 4.05% |
| 2014 FY | 1.81 Billion CNY | 15.45% |
| 2014 Q1 | 1.6 Billion CNY | 2.24% |
| 2014 Q2 | 1.65 Billion CNY | 3.43% |
| 2013 Q3 | 1.5 Billion CNY | 1.88% |
| 2013 FY | 1.56 Billion CNY | 9.53% |
| 2013 Q4 | 1.56 Billion CNY | 4.38% |
| 2013 Q2 | 1.47 Billion CNY | 1.47% |
| 2013 Q1 | 1.45 Billion CNY | 1.5% |
| 2012 FY | 1.43 Billion CNY | 24.67% |
| 2012 Q1 | 1.19 Billion CNY | 3.59% |
| 2012 Q2 | 1.21 Billion CNY | 2.35% |
| 2012 Q3 | 1.26 Billion CNY | 4.12% |
| 2012 Q4 | 1.43 Billion CNY | 12.93% |
| 2011 Q4 | 1.14 Billion CNY | 5.07% |
| 2011 FY | 1.14 Billion CNY | 333.93% |
| 2011 Q2 | 1.07 Billion CNY | 266.18% |
| 2011 Q3 | 1.09 Billion CNY | 2.22% |
| 2011 Q1 | 292.26 Million CNY | 10.34% |
| 2010 Q4 | 264.88 Million CNY | 10.22% |
| 2010 FY | 264.88 Million CNY | 78.07% |
| 2010 Q3 | 240.32 Million CNY | 0.0% |
| 2009 FY | 148.75 Million CNY | 61.57% |
| 2008 FY | 92.06 Million CNY | 11.98% |
| 2007 FY | 82.21 Million CNY | 0.0% |